U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2C2H3O2.3Pb.4HO
Molecular Weight 813.8
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LEAD SUBACETATE

SMILES

[OH-].[OH-].[OH-].[OH-].[PbH2++].[PbH2++].[PbH2++].CC([O-])=O.CC([O-])=O

InChI

InChIKey=ZVYXAPIZECHZKT-UHFFFAOYSA-H
InChI=1S/2C2H4O2.4H2O.3Pb.6H/c2*1-2(3)4;;;;;;;;;;;;;/h2*1H3,(H,3,4);4*1H2;;;;;;;;;/q;;;;;;3*+2;;;;;;/p-6

HIDE SMILES / InChI

Molecular Formula HO
Molecular Weight 17.0073
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C2H3O2
Molecular Weight 59.044
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Pb
Molecular Weight 209.2
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Lead(II) acetate is a white crystalline chemical compound with a sweetish taste. Lead(II) acetate is used as a mordant in textile printing and dyeing, as a drier in paints and varnishes, and in preparing other lead compounds. It was historically used as a sweetener and for cosmetics.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
A review of selected chemical additives in cosmetic products.
2014-07-24
The protective effect of flaxseed oil on lead acetate-induced renal toxicity in rats.
2011-10-30
Coordinated waves of gene expression during neuronal differentiation of embryonic stem cells as basis for novel approaches to developmental neurotoxicity testing.
2011-03
Scope and mechanism of intramolecular aziridination of cyclopent-3-enyl-methylamines to 1-azatricyclo[2.2.1.0(2,6)]heptanes with lead tetraacetate.
2009-08-26
Hypertrophy and increased glial fibrillary acidic protein are coupled to increased protection against cytotoxicity in glioma cell lines.
1998-04
Clastogenicity evaluation of seven chemicals commonly found at hazardous industrial waste sites.
1989-12
Chromosomal effects of lead: A critical review.
1980
The mechanism of the lead tetraacetate oxidation of a B-norsteroid.
1967-08-15
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
It was examined the associations of increased glial fibrillary acidic protein (GFAP) levels and hypertrophie changes with susceptibility to toxic insult in C6 rat glioma cells. The cells were treated with serial pulses of dibutyryl-cAMP (dBcAMP) (each 48 hr) which increased levels of GFAP approximately twofold and the surface to volume ratio by approximately 1.7 times after the third pulse. This treatment reduced cell number by 22% and increased total protein by 10%. The cells were then exposed to different toxic substances [tin chloride, lead tetraacetate, chloroquine, cadmium chloride, aluminium chloride, mercuric chloride, acrylamide, triethyltin bromide, ethylenediaminetetraacetatic acid (EDTA)] and toxicity to the cells measured by the neutral red (NR) assay. With the exceptions of aluminium chloride and EDTA, 50% effective concentration (EC(50)) values for the toxic substances were increased up to 10,000 times (for cadmium chloride).
Substance Class Chemical
Created
by admin
on Mon Mar 31 22:00:13 GMT 2025
Edited
by admin
on Mon Mar 31 22:00:13 GMT 2025
Record UNII
BW7DT27250
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GOULARD'S EXTRACT
Preferred Name English
LEAD SUBACETATE
MI  
Common Name English
BIS(ACETATE)TETRAHYDROXYTRILEAD
Systematic Name English
LEAD SUBACETATE [MI]
Common Name English
LEAD ACETATE BASIC
Common Name English
Code System Code Type Description
ECHA (EC/EINECS)
215-630-3
Created by admin on Mon Mar 31 22:00:13 GMT 2025 , Edited by admin on Mon Mar 31 22:00:13 GMT 2025
PRIMARY
WIKIPEDIA
Basic lead acetate
Created by admin on Mon Mar 31 22:00:13 GMT 2025 , Edited by admin on Mon Mar 31 22:00:13 GMT 2025
PRIMARY
HSDB
1651
Created by admin on Mon Mar 31 22:00:13 GMT 2025 , Edited by admin on Mon Mar 31 22:00:13 GMT 2025
PRIMARY
FDA UNII
BW7DT27250
Created by admin on Mon Mar 31 22:00:13 GMT 2025 , Edited by admin on Mon Mar 31 22:00:13 GMT 2025
PRIMARY
CAS
1335-32-6
Created by admin on Mon Mar 31 22:00:13 GMT 2025 , Edited by admin on Mon Mar 31 22:00:13 GMT 2025
PRIMARY
SMS_ID
100000176033
Created by admin on Mon Mar 31 22:00:13 GMT 2025 , Edited by admin on Mon Mar 31 22:00:13 GMT 2025
PRIMARY
PUBCHEM
5284406
Created by admin on Mon Mar 31 22:00:13 GMT 2025 , Edited by admin on Mon Mar 31 22:00:13 GMT 2025
PRIMARY
MERCK INDEX
m6744
Created by admin on Mon Mar 31 22:00:13 GMT 2025 , Edited by admin on Mon Mar 31 22:00:13 GMT 2025
PRIMARY Merck Index